Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 4

The DOI matches its Crossref record.

Epidermal growth factor receptor pathway in central nervous system regenerative medicine: a narrative review

Badenes, Marina · 2024 · Regenerative Medicine Reports

Abstract

The epidermal growth factor receptor (signaling pathway is involved in numerous important mammal cell functions, such as growth, survival, proliferation, and differentiation. Associated with this, it is involved in tissue normal development and growth, tumorigenesis, and in tissue repair. Epidermal growth factor receptor is broadly expressed in the organism, including in the central and peripheral nervous system, where it has important neurotrophic functions. The central nervous system has a limited capacity for regeneration upon lesion, leading to severe disabilities, such as blindness, sensorimotor deficits, and paralysis. However, observations suggest that its innate neurogenic response may be amplified to promote the replenishment of damaged neuronal populations. In addition, the environment can also be modulated to promote regeneration. Therefore, the pathways involved in neural tissue repair have been investigated in terms of regenerative medicine, to discover new therapies to recover from traumatic injury or ischemia in the central nervous system or to inhibit the progression of neurodegenerative diseases. Growth factors have been widely accepted as the most important promoters of proliferation and neurogenesis under physiologic conditions and after injury. In this review, we summarize how the epidermal growth factor receptor signaling pathway is involved in neuronal damage and neurodegeneration in several settings, including in the olfactory epithelium, brain, spinal cord, and optic nerve, where this pathway can be modulated in the context of regenerative medicine to promote neuronal regeneration and, therefore, neurological function reestablishment in response to insults.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/regenmed.regenmed-d-24-00020

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 69

  1. 2024, Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021, Lancet Neurol, 23, 344, 10.1016/S1474-4422(24)00038-3 · DOI · Paper page
  2. Romano, 2020, Role of EGFR in the nervous system, Cells, 9, 1887, 10.3390/cells9081887 · DOI · Paper page
  3. Robson, 2018, Impaired neural stem cell expansion and hypersensitivity to epileptic seizures in mice lacking the EGFR in the brain, FEBS J, 285, 3175, 10.1111/febs.14603 · DOI
  4. Tavassoly, 2020, Inhibition of brain epidermal growth factor receptor activation: a novel target in neurodegenerative diseases and brain injuries, Mol Pharmacol, 98, 13, 10.1124/mol.120.119909 · DOI
  5. Shaban, 2023, Targeted inhibitors of EGFR: structure, biology, biomarkers, and clinical applications, Cells, 13, 47, 10.3390/cells13010047 · DOI
  6. Kim, 2020, Role of heparin-binding epidermal growth factor-like growth factor in oxidative stress-associated metabolic diseases, Metab Syndr Relat Disord, 18, 186, 10.1089/met.2019.0120 · DOI
  7. Fang, 2023, The role of amphiregulin in ovarian function and disease, Cell Mol Life Sci, 80, 60, 10.1007/s00018-023-04709-8 · DOI
  8. Duffy, 2011, The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?, Clin Proteomics, 8, 9, 10.1186/1559-0275-8-9 · DOI · Paper page
  9. Taylor, 2014, Heparin-binding epidermal growth factor-like growth factor (HB-EGF) and proteolytic processing by a disintegrin and metalloproteinases (ADAM): a regulator of several pathways, Semin Cell Dev Biol, 28, 22, 10.1016/j.semcdb.2014.03.004 · DOI
  10. Rosenbaum, 2024, New insights into the function and pathophysiology of the ectodomain sheddase A Disintegrin And Metalloproteinase 10 (ADAM10), FEBS J, 291, 2733, 10.1111/febs.16870 · DOI
  11. Saad, 2024, The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond, FEBS J, 291, 10, 10.1111/febs.16923 · DOI
  12. Adrain, 2020, The complex life of rhomboid pseudoproteases, FEBS J, 287, 4261, 10.1111/febs.15548 · DOI
  13. Cavadas, 2017, Phosphorylation of iRhom2 controls stimulated proteolytic shedding by the metalloprotease ADAM17/TACE, Cell Rep, 21, 745, 10.1016/j.celrep.2017.09.074 · DOI
  14. Badenes, 2020, Deletion of iRhom2 protects against diet-induced obesity by increasing thermogenesis, Mol Metab, 31, 67, 10.1016/j.molmet.2019.10.006 · DOI
  15. Badenes, 2019, iRhom2 and TNF: Partners or enemies?, Sci Signal, 12, eaaz0444, 10.1126/scisignal.aaz0444 · DOI
  16. Oikonomidi, 2018, iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE, Elife, 7, e35032, 10.7554/eLife.35032 · DOI
  17. Badenes, 2023, The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth, Life Sci Alliance, 6, e202201644, 10.26508/lsa.202201644 · DOI
  18. Calligaris, 2021, Strategies to target ADAM17 in disease: from its discovery to the iRhom revolution, Molecules, 26, 944, 10.3390/molecules26040944 · DOI
  19. Bleibaum, 2019, ADAM10 sheddase activation is controlled by cell membrane asymmetry, J Mol Cell Biol, 11, 979, 10.1093/jmcb/mjz008 · DOI
  20. Rosenkranz, 2020, Epidermal growth factor receptor: key to selective intracellular delivery, Biochemistry (Mosc), 85, 967, 10.1134/S0006297920090011 · DOI
  21. Gao, 2022, Restoring after central nervous system injuries: neural mechanisms and translational applications of motor recovery, Neurosci Bull, 38, 1569, 10.1007/s12264-022-00959-x · DOI
  22. Sireci, 2024, HB-EGF promotes progenitor cell proliferation and sensory neuron regeneration in the zebrafish olfactory epithelium, FEBS J, 291, 2098, 10.1111/febs.17033 · DOI
  23. Getchell, 2000, Horizontal basal cell proliferation in the olfactory epithelium of transforming growth factor-alpha transgenic mice, Cell Tissue Res, 299, 185
  24. Chen, 2020, Matrix metalloprotease-mediated cleavage of neural glial-related cell adhesion molecules activates quiescent olfactory stem cells via EGFR, Mol Cell Neurosci, 108, 103552, 10.1016/j.mcn.2020.103552 · DOI
  25. Adrain, 2024, Can the HB-EGF/EGFR pathway restore injured neurons?, FEBS J, 291, 2094, 10.1111/febs.17143 · DOI
  26. Scalabrino, 2022, Epidermal growth factor in the CNS: A beguiling journey from integrated cell biology to multiple sclerosis. an extensive translational overview, Cell Mol Neurobiol, 42, 891, 10.1007/s10571-020-00989-x · DOI
  27. Bielefeld, 2024, Traumatic brain injury promotes neurogenesis at the cost of astrogliogenesis in the adult hippocampus of male mice, Nat Commun, 15, 5222, 10.1038/s41467-024-49299-6 · DOI
  28. Chen, 2019, Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation, Sci Rep, 9, 2516, 10.1038/s41598-019-38676-7 · DOI
  29. Pastor-Alonso, 2024, HB-EGF activates EGFR to induce reactive neural stem cells in the mouse hippocampus after seizures, Life Sci Alliance, 7, e202201840, 10.26508/lsa.202201840 · DOI
  30. Yu, 2024, A novel network pharmacology strategy based on the universal effectiveness-common mechanism of medical herbs uncovers therapeutic targets in traumatic brain injury, Drug Des Devel Ther, 18, 1175, 10.2147/DDDT.S450895 · DOI
  31. Gómez-Oliva, 2023, Targeting epidermal growth factor receptor to recruit newly generated neuroblasts in cortical brain injuries, J Transl Med, 21, 867, 10.1186/s12967-023-04707-1 · DOI
  32. Sun, 2010, The effect of epidermal growth factor in the injured brain after trauma in rats, J Neurotrauma, 27, 923, 10.1089/neu.2009.1209 · DOI
  33. Teramoto, 2003, EGF amplifies the replacement of parvalbumin-expressing striatal interneurons after ischemia, J Clin Invest, 111, 1125, 10.1172/JCI200317170 · DOI
  34. Ninomiya, 2006, Enhanced neurogenesis in the ischemic striatum following EGF-induced expansion of transit-amplifying cells in the subventricular zone, Neurosci Lett, 403, 63, 10.1016/j.neulet.2006.04.039 · DOI
  35. Jurkowski, 2020, Beyond the hippocampus and the SVZ: adult neurogenesis throughout the brain, Front Cell Neurosci, 14, 576444, 10.3389/fncel.2020.576444 · DOI · Paper page
  36. Wang, 2023, Myricetin suppresses traumatic brain injury-induced inflammatory response via EGFR/AKT/STAT pathway, Sci Rep, 13, 22764, 10.1038/s41598-023-50144-x · DOI
  37. Solou, 2023, Management of neurological complications related to aneurysmal subarachnoid hemorrhage: A comparison of the bedside therapeutic algorithms, Surgeon, 21, e328, 10.1016/j.surge.2023.06.006 · DOI
  38. Nakano, 2023, Epidermal growth factor receptor mediates neuronal apoptosis after subarachnoid hemorrhage in mice, Stroke, 54, 1616, 10.1161/STROKEAHA.122.041977 · doi:10.1161/strokeaha.122.041977
  39. Suzuki, 2020, Tenascin-C in brain injuries and edema after subarachnoid hemorrhage: Findings from basic and clinical studies, J Neurosci Res, 98, 42, 10.1002/jnr.24330 · DOI
  40. Shiba, 2014, Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats, Transl Stroke Res, 5, 238, 10.1007/s12975-014-0333-2 · DOI
  41. Fujimoto, 2016, Epidermal growth factor-like repeats of tenascin-C-induced constriction of cerebral arteries via activation of epidermal growth factor receptors in rats, Brain Res, 1642, 436, 10.1016/j.brainres.2016.04.034 · DOI
  42. Nakatsuka, 2017, Preventive effects of cilostazol against the development of shunt-dependent hydrocephalus after subarachnoid hemorrhage, J Neurosurg, 127, 319, 10.3171/2016.5.JNS152907 · DOI
  43. Peng, 2019, Activation of GPR30 with G1 attenuates neuronal apoptosis via src/EGFR/stat3 signaling pathway after subarachnoid hemorrhage in male rats, Exp Neurol, 320, 113008, 10.1016/j.expneurol.2019.113008 · DOI
  44. Nakano, 2019, Anti-vasospastic effects of epidermal growth factor receptor inhibitors after subarachnoid hemorrhage in mice, Mol Neurobiol, 56, 4730, 10.1007/s12035-018-1400-6 · DOI
  45. Li, 2021, Blocking the EGFR/p38/NF-κB signaling pathway alleviates disruption of BSCB and subsequent inflammation after spinal cord injury, Neurochem Int, 150, 105190, 10.1016/j.neuint.2021.105190 · DOI
  46. Tran, 2022, New insights into glial scar formation after spinal cord injury, Cell Tissue Res, 387, 319, 10.1007/s00441-021-03477-w · DOI · Paper page
  47. Li, 2014, Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury, J Neuroinflammation, 11, 71, 10.1186/1742-2094-11-71 · DOI
  48. Qu, 2012, Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury, J Neuroinflammation, 9, 178, 10.1186/1742-2094-9-178 · DOI · Paper page
  49. Piletsky, 2023, Modulation of EGFR activity by molecularly imprinted polymer nanoparticles targeting intracellular epitopes, Nano Lett, 23, 9677, 10.1021/acs.nanolett.3c01374 · DOI
  50. Ju, 2012, Induction of neuronal phenotypes from NG2+ glial progenitors by inhibiting epidermal growth factor receptor in mouse spinal cord injury, Glia, 60, 1801, 10.1002/glia.22398 · DOI
  51. Li, 2011, Inhibiting epidermal growth factor receptor attenuates reactive astrogliosis and improves functional outcome after spinal cord injury in rats, Neurochem Int, 58, 812, 10.1016/j.neuint.2011.03.007 · DOI
  52. Goldshmit, 2016, Nucleolin inhibitor GroA triggers reduction in epidermal growth factor receptor activation: Pharmacological implication for glial scarring after spinal cord injury, J Neurochem, 138, 845, 10.1111/jnc.13730 · DOI
  53. Xue, 2020, Epidermal growth factor receptor-extracellular-regulated kinase blockade upregulates TRIM32 signaling cascade and promotes neurogenesis after spinal cord injury, Stem Cells, 38, 118, 10.1002/stem.3097 · DOI
  54. Qin, 2024, Local delivery of EGFR, Bioact Mater, 33, 424
  55. Cigliola, 2023, Spinal cord repair is modulated by the neurogenic factor Hb-egf under direction of a regeneration-associated enhancer, Nat Commun, 14, 4857, 10.1038/s41467-023-40486-5 · DOI
  56. Zeng, 2023, The promising role of a zebrafish model employed in neural regeneration following a spinal cord injury, Int J Mol Sci, 24, 13938, 10.3390/ijms241813938 · DOI
  57. Jin, 2021, Blood-spinal cord barrier in spinal cord injury: a review, J Neurotrauma, 38, 1203, 10.1089/neu.2020.7413 · DOI · Paper page
  58. Liu, 2019, Vascular endothelial growth factor activates neural stem cells through epidermal growth factor receptor signal after spinal cord injury, CNS Neurosci Ther, 25, 375, 10.1111/cns.13056 · DOI
  59. Zheng, 2016, Epidermal growth factor attenuates blood-spinal cord barrier disruption via PI3K/Akt/Rac1 pathway after acute spinal cord injury, J Cell Mol Med, 20, 1062, 10.1111/jcmm.12761 · DOI
  60. Lv, 2024, EGFR-activated JAK2/STAT3 pathway confers neuroprotection in spinal cord ischemia-reperfusion injury: evidence from high-throughput sequencing and experimental models, Mol Neurobiol, 61, 646, 10.1007/s12035-023-03548-9 · DOI
  61. Lee, 2024, Optic nerve regeneration: Potential treatment approaches, Curr Opin Pharmacol, 74, 102428, 10.1016/j.coph.2023.102428 · DOI
  62. Fague, 2021, The basic science of optic nerve regeneration, Ann Transl Med, 9, 1276, 10.21037/atm-20-5351 · DOI
  63. Yang, 2021, Axon regeneration after optic nerve injury in rats can be improved via PirB knockdown in the retina, Cell Biosci, 11, 158, 10.1186/s13578-021-00670-w · DOI
  64. Zhu, 2023, Astrocytes in the optic nerve are heterogeneous in their reactivity to glaucomatous injury, Cells, 12, 2131, 10.3390/cells12172131 · DOI
  65. Liu, 2006, Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury, J Neurosci, 26, 7532, 10.1523/JNEUROSCI.1004-06.2006 · DOI · Paper page
  66. Liu, 2003, Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy, Neurobiol Dis, 13, 109, 10.1016/S0969-9961(03)00010-X · DOI
  67. Koprivica, 2005, EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans, Science, 310, 106, 10.1126/science.1115462 · DOI · Paper page
  68. Harder, 2017, Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective, Proc Natl Acad Sci U S A, 114, E3839, 10.1073/pnas.1608769114 · DOI
  69. Li, 2024, Kinase inhibitors and kinase-targeted cancer therapies: recent advances and future perspectives, Int J Mol Sci, 25, 5489, 10.3390/ijms25105489 · DOI

Metadata

Authors
Badenes, M.
Affiliations
Veterinary Medicine Research (I-MVET), Faculty of Veterinary Medicine, Lusófona University - Lisbon University Center, Lisbon, Portugal
Venue
Regenerative Medicine Reports
Published
2024-12
Volume
1
Issue
2
Pages
172-186
ISSN
  • 3050-6794
  • 3050-6808
Cited by
4
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidermal growth factor receptor pathway in central nervous system regenerative medicine: a narrative review. https://app.cochat.ai/papers/10.4103/regenmed.regenmed-d-24-00020
The paper
Badenes, M. (2024). Epidermal growth factor receptor pathway in central nervous system regenerative medicine: a narrative review. Regenerative Medicine Reports. https://doi.org/10.4103/regenmed.regenmed-d-24-00020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.